Tag: personalized medicine diagnostics

April 19, 2017

Canopy Growth Corporation Enters Into An Agreement with Invictus MD's AB Laboratories For Cannabis Sales

Invictus MD (TSXV:IMH) is pleased to announce that AB Laboratories Inc. ("AB Labs"), a Licensed Producer under the Access to...
April 13, 2017

Invictus MD's Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector

Invictus MD (TSXV:IMH) is pleased to report that Future Harvest Development Ltd. ("Future Harvest"), of which Invictus MD currently owns...
April 11, 2017

Invictus MD's Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis

Acreage Pharms Ltd., which Invictus MD (CNX:IMH). has the option to now acquire 100 per cent of and expects to...
March 31, 2017

Invictus MD Moves To TSX Venture Exchange

Invictus MD (CNX:IMH), Canada's cannabis company, is pleased to announce that its common shares will be delisted from the Canadian...
March 28, 2017

Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market

Invictus MD Strategies Corp. CNX:IMH) is providing an update of its production capability in preparation for the recreational cannabis market....
March 27, 2017

Invictus MD Announces Conditional Approval to List on the TSX Venture Exchange

Invictus MD (CNX:IMH) is pleased to announce it has received conditional approval to list its common shares for trading on...
March 24, 2017

Invictus MD Strategies Appoints George E. Kveton to Board of Directors.

Invictus MD (CNX:IMH) - Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad...